seed
Stage
3
Investors
About
Entropix Ltd develops and commercializes advanced technologies for the purification of proteins and nucleic acids, including proprietary platforms such as NADA™ for nucleic acid purification and SCOPE™ for protein fractionation, targeting applications in molecular biology, proteomics, genomics, and biopharmaceutical production.
Explore Entropix Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.